Schwab Andrew J.

10% owner at Enliven Therapeutics, Inc. · on record since Apr 6, 2023
10% owner at Skye Bioscience, Inc. · on record since Aug 22, 2023
10% owner at Artiva Biotherapeutics, Inc. · on record since Jul 24, 2024
Director at Skye Bioscience, Inc. · on record since Apr 2, 2026
Director at Flexion Therapeutics Inc · on record since Feb 20, 2014
10% owner at Flexion Therapeutics Inc · on record since Feb 20, 2014
10% owner at VIVEVE MEDICAL, INC. · on record since Sep 25, 2014
10% owner at Enterprise Informatics Inc · on record since Jul 25, 2014
10% owner at Cidara Therapeutics, Inc. · on record since Apr 22, 2015
10% owner at PHASERX, INC. · on record since May 23, 2016
10% owner at LOT78, INC. · on record since Jul 19, 2016
10% owner at Latigo Biotherapeutics, Inc. · on record since Aug 6, 2026
former 10% owner at LOT78, INC. · on record since Apr 26, 2017
10% owner at scPharmaceuticals Inc. · on record since Nov 21, 2017
10% owner at Q32 Bio Inc. · on record since Mar 27, 2018
10% owner at ARVINAS, INC. · on record since Sep 26, 2018
10% owner at Crinetics Pharmaceuticals, Inc. · on record since Jul 20, 2018
10% owner at IDEAYA Biosciences, Inc. · on record since May 28, 2019
Former 10% holder at · on record since Jun 25, 2019
10% owner at · on record since Oct 31, 2019
10% owner at · on record since Oct 9, 2019
10% owner at · on record since Jun 25, 2020
Director at · on record since Oct 20, 2020
Co-CEO at · on record since Oct 20, 2020
10% owner at · on record since Oct 20, 2020
Former 10% holder at · on record since Oct 7, 2020
10% owner at · on record since Jul 29, 2021
10% owner at · on record since Feb 9, 2021
10% owner at · on record since Apr 29, 2021
10% owner at · on record since Oct 28, 2021
Director at · on record since Dec 7, 2021
10% owner at · on record since Dec 7, 2021
10% owner at · on record since Jan 13, 2022
Director at · on record since Feb 27, 2023
Director at · on record since Jun 12, 2026
10% owner at · on record since Jun 12, 2026

Insider trading activity of Schwab Andrew J.

Transactions on record: 129; since Feb 20, 2014

Open-market buys: 4; $25M

Open-market sells: 62; $59.7M

Companies traded: 16; last filing Sep 24, 2026

Figures computed from official regulatory filings — .

Companies where Schwab Andrew J. has traded

40 tx · $28M · Sep 24, 2026
16 tx · $21.9M · Aug 31, 2026
17 tx · $5.9M · Jul 1, 2025
5 tx · $7M · Aug 28, 2023
1 tx · $820K · Mar 9, 2023
3 tx · Feb 28, 2023
2 tx · Dec 2, 2022
10 tx · $2.7M · Aug 18, 2022
2 tx · $5.1M · Nov 18, 2021
9 tx · $6.7M · Dec 16, 2020
6 tx · $9.4M · Dec 14, 2020
5 tx · $3.7M · Dec 1, 2020
3 tx · $10.9M · Nov 13, 2020
1 tx · $5M · May 28, 2020

Track record of Schwab Andrew J.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Schwab Andrew J.

Co-insiders of Schwab Andrew J.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-27,612	1.65 USD	$45.6K		SEC
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-1,088	1.65 USD	$1.8K		SEC
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-4,528	1.61 USD	$7.3K		SEC
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-114,851	1.61 USD	$184.9K		SEC
Skye Bioscience, Inc.Listing on record	Sep 18, 2026	Sell	-1,285	1.91 USD	$2.5K		SEC
Skye Bioscience, Inc.Listing on record	Sep 18, 2026	Sell	-32,607	1.91 USD	$62.3K		SEC
Camp4 Therapeutics CorpListing on record	Aug 31, 2026	Sell	-400,000	4.04 USD	$1.6M	Unusual size	SEC
Camp4 Therapeutics CorpListing on record	Aug 26, 2026	Sell	-10	4.50 USD	$45		SEC
Camp4 Therapeutics CorpListing on record	Aug 21, 2026	Sell	-45,147	4.76 USD	$214.9K		SEC
Camp4 Therapeutics CorpListing on record	Aug 21, 2026	Sell	-32,018	4.50 USD	$144.1K		SEC
Camp4 Therapeutics CorpListing on record	Aug 21, 2026	Sell	-114,700	4.54 USD	$520.7K	Unusual size	SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-10,255	0.35 USD	$3.6K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-409	0.35 USD	$143.1		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-57,476	0.35 USD	$20.1K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-6,495	0.32 USD	$2.1K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-253,080	0.38 USD	$96.2K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-1,830	0.38 USD	$695.4		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-45,090	0.38 USD	$17.1K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-1,159	0.32 USD	$370.9		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-46	0.32 USD	$14.7		SEC
Camp4 Therapeutics CorpListing on record	Aug 5, 2026	AwardD (derivative)	3,179,558	1.53 USD	$4.9M		SEC
Camp4 Therapeutics CorpListing on record	Jun 12, 2026	AwardD (derivative)	28,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Apr 2, 2026	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Feb 9, 2026	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Camp4 Therapeutics CorpListing on record	Sep 15, 2025	Award	2,941,176	1.53 USD	$4.5M		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-27,612	1.65 USD	$45.6K		SEC
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-1,088	1.65 USD	$1.8K		SEC
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-4,528	1.61 USD	$7.3K		SEC
Skye Bioscience, Inc.Listing on record	Sep 24, 2026	Sell	-114,851	1.61 USD	$184.9K		SEC
Skye Bioscience, Inc.Listing on record	Sep 18, 2026	Sell	-1,285	1.91 USD	$2.5K		SEC
Skye Bioscience, Inc.Listing on record	Sep 18, 2026	Sell	-32,607	1.91 USD	$62.3K		SEC
Camp4 Therapeutics CorpListing on record	Aug 31, 2026	Sell	-400,000	4.04 USD	$1.6M	Unusual size	SEC
Camp4 Therapeutics CorpListing on record	Aug 26, 2026	Sell	-10	4.50 USD	$45		SEC
Camp4 Therapeutics CorpListing on record	Aug 21, 2026	Sell	-45,147	4.76 USD	$214.9K		SEC
Camp4 Therapeutics CorpListing on record	Aug 21, 2026	Sell	-32,018	4.50 USD	$144.1K		SEC
Camp4 Therapeutics CorpListing on record	Aug 21, 2026	Sell	-114,700	4.54 USD	$520.7K	Unusual size	SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-10,255	0.35 USD	$3.6K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-409	0.35 USD	$143.1		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-57,476	0.35 USD	$20.1K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-6,495	0.32 USD	$2.1K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-253,080	0.38 USD	$96.2K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-1,830	0.38 USD	$695.4		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-45,090	0.38 USD	$17.1K		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-1,159	0.32 USD	$370.9		SEC
Skye Bioscience, Inc.Listing on record	Aug 20, 2026	Sell	-46	0.32 USD	$14.7		SEC
Camp4 Therapeutics CorpListing on record	Aug 5, 2026	AwardD (derivative)	3,179,558	1.53 USD	$4.9M		SEC
Camp4 Therapeutics CorpListing on record	Jun 12, 2026	AwardD (derivative)	28,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Apr 2, 2026	AwardD (derivative)	75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Skye Bioscience, Inc.Listing on record	Feb 9, 2026	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Camp4 Therapeutics CorpListing on record	Sep 15, 2025	Award	2,941,176	1.53 USD	$4.5M		SEC